These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6745081)

  • 21. NONLIN84/PCNONLIN: software for the statistical analysis of nonlinear models.
    Weiner DL
    Methods Find Exp Clin Pharmacol; 1986 Oct; 8(10):625-8. PubMed ID: 3784700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of the modified one-compartment open model in pharmacokinetic investigations.
    Bialik W
    Pharmazie; 1985 Feb; 40(2):120-1. PubMed ID: 4001147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: routine clinical pharmacokinetic data.
    Sheiner LB; Beal SL
    J Pharmacokinet Biopharm; 1983 Jun; 11(3):303-19. PubMed ID: 6644555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noncompartmental approach in pharmacokinetics using moments.
    Nüesch EA
    Drug Metab Rev; 1984; 15(1-2):103-31. PubMed ID: 6378559
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data.
    Sheiner LB; Beal SL
    J Pharmacokinet Biopharm; 1980 Dec; 8(6):553-71. PubMed ID: 7229908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analytical approximations of sensitivities of steady state predictions to errors in parameter estimation.
    Gonda I
    J Pharmacokinet Biopharm; 1982 Oct; 10(5):559-74. PubMed ID: 7166739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of new measures of nonlinearity to parameter estimation and simulations in individual pharmacokinetic analyses.
    Khinkis L; Crotzer M
    J Pharmacokinet Pharmacodyn; 2019 Feb; 46(1):43-52. PubMed ID: 30607795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A simulation study of parameter estimation in the one and two compartment models.
    Laskarzewski PM; Weiner DL; Ott L
    J Pharmacokinet Biopharm; 1982 Jun; 10(3):317-34. PubMed ID: 7175702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frontiers in pharmacokinetic data analysis.
    Drug Metab Rev; 1984; 15(1-2):1-400. PubMed ID: 6745078
    [No Abstract]   [Full Text] [Related]  

  • 30. Estimation of statistical moments and steady-state volume of distribution for a drug given by intravenous infusion.
    Chan KK; Gibaldi M
    J Pharmacokinet Biopharm; 1982 Oct; 10(5):551-8. PubMed ID: 7166738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Procedure for fitting pharmacokinetic data: a comparison of programs and the importance of the weight of the data].
    Testa R; Vanasia A; Bertin D
    Farmaco Prat; 1984 Jun; 39(6):199-210. PubMed ID: 6547682
    [No Abstract]   [Full Text] [Related]  

  • 32. Model-independent procedure for area estimation and intergroup comparisons.
    Capizzi T; Mehta H; Oppenheimer L
    J Pharm Sci; 1983 Sep; 72(9):995-9. PubMed ID: 6631712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On some stochastic formulations and related statistical moments of pharmacokinetic models.
    Matis JH; Wehrly TE; Metzler CM
    J Pharmacokinet Biopharm; 1983 Feb; 11(1):77-92. PubMed ID: 6875812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A note on confidence intervals with extended least squares parameter estimates.
    Sheiner LB; Beal SL
    J Pharmacokinet Biopharm; 1987 Feb; 15(1):93-8. PubMed ID: 3625482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of drug binding parameters.
    Luecke RH; Wosilait WD
    J Pharmacokinet Biopharm; 1986 Feb; 14(1):65-78. PubMed ID: 2427682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimation of pharmacokinetic parameters: statistical considerations.
    Metzler CM
    Pharmacol Ther; 1981; 13(3):543-56. PubMed ID: 7025040
    [No Abstract]   [Full Text] [Related]  

  • 37. Problems and pitfalls in estimating average pharmacokinetic parameters.
    Martin E; Moll W; Schmid P; Dettli L
    Eur J Clin Pharmacol; 1984; 26(5):595-602. PubMed ID: 6468475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of pharmacokinetic data using parametric models--1: Regression models.
    Sheiner LB
    J Pharmacokinet Biopharm; 1984 Feb; 12(1):93-117. PubMed ID: 6747821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An alternative method for calculating simple pharmacokinetic parameters for zero-order absorption and first-order elimination processes.
    Bialer M
    Biopharm Drug Dispos; 1981; 2(4):323-7. PubMed ID: 7317571
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of drug absorption by nonlinear regression, statistical moments, and Loo-Riegelman methods.
    Patel IH; Bornemann L; Colburn WA
    J Pharm Sci; 1985 Mar; 74(3):359-60. PubMed ID: 4009451
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.